All News

The FDA will speed up their review of CYNK-101 plus chemotherapy and immune checkpoint inhibitors for the treatment of advanced HER2-postivie gastric or gastroesophageal adenocarcinomas.

The STELLAR-002 trial is currently underway to examine the combination of XL092, an experimental tyrosine kinase inhibitor, in combination with immuno-oncology therapies for patients with advanced solid tumors.

Prostate cancer survivors are encouraged to include their partners in interventions to improve sexual function after treatment — and, as study results show, it is better to have these conversations with providers sooner rather than later.

After the drug showed promising results in the DESTINY-Breast03 trial, the FDA granted Enhertu a priority review, meaning that it plans to make its approval decision on it by the end of the second quarter of 2022.

One breast cancer survivor shares the experience she had with her daughters in trying to get them to understand the importance of participating in preventive screenings.

The survey results also showed that those who have received a cancer diagnosis have faced more setbacks when it comes to working during the pandemic.

One woman explains how after experiencing irregular bleeding, she found out she had cervical cancer and her life changed immediately.

A brain tumor survivor explains how she chooses to approach life with acceptance of the hard times rather than trying to throw them away.

While robotic navigational bronchoscopy is an exciting advancement in diagnosing and staging lung cancer, the procedure does come with some risks and factors to consider, explained one expert.

A cancer survivor offers advice for those facing anxiety and fear about cancer that takes control of their life.

New findings demonstrated that adult patients with breast cancer and increased BMI had an association with different types of immune cells around their tumors that may affect how their body attacks the cancer cells.

A cancer survivor expresses the fears many survivors face with another year of staring down the COVID-19 pandemic.

From the deaths of singer Ronnie Spector and famed cancer researcher Beatrice Mintz to a patient who became his own biggest advocate after a stranger noticed a suspicious spot on his back, here’s what’s happening in the cancer landscape this week.

CAR-T cell therapy with Yescarta in patients with relapsed/refractory large B-cell lymphoma had improved responses to treatment and survival in the second-line setting, which may help save more lives than standard care, an expert said.

Enrollment has begun for a trial evaluating a vaccine as first-line maintenance treatment for metastatic, microsatellite-stable colorectal cancer.

An infectious disease expert explains the new and upcoming treatment modalities that are improving COVID-19 outcomes for patients with cancer and other conditions that compromise the immune system.

A nursing student describes how the day her sister was diagnosed with cancer shaped her world in many ways and caused a domino effect on her life.

In this episode of the “Cancer Horizons” podcast, a physician assistant recalls his experience as a frontline health care worker during the COVID-19 pandemic and what it was like to get diagnosed with multiple myeloma during such a chaotic time.

Although patients with multiple myeloma may be concerned that a reduction in treatment dose may be less effective, an expert from The Tisch Cancer Institute stresses that it may be more beneficial.

A recent study demonstrated that a lower dose of radiation after surgery for HPV-related throat cancer may provide a greater benefit than a higher dose of radiation with chemotherapy.

One cancer survivor describes the impact of the words of support from other patients with cancer throughout his experience that helped pull him out of devastation.

After not knowing quite what to expect from her first chemotherapy treatment, colorectal cancer survivor Yla Flores describes the pain she felt in her heart after seeing other patients in worse conditions.

A phase 3 trial has begun to examine entospletinib, a selective inhibitor, as a treatment for patients with newly diagnosed NPM1-mutated acute myeloid leukemia.

Sexual dysfunction may often happen after prostate cancer treatment, and the results of one study shown that an online program for both the patient and their partner may help in this aspect of recovery.

The National Comprehensive Cancer Network now recommends prophylactic monoclonal antibodies for immunosuppressed individuals, such as certain patients with cancer.

A cancer survivor explains how she was able to intimately reconnect with her spouse after cancer caused their love life to fizzle for many years.

In an interim analysis from a phase 3 trial of Keytruda, the use of the immunotherapy drug was associated with significantly improved disease-free survival in patients with non-small cell lung cancer.

From mouth sores to cold sensitivities as well as a continued taste of chemicals, cancer survivors recently shared some of the more unexpected side effects they experienced during and after treatment.

A phase 2 trial was recently launched to examine the safety and efficacy of oral inhibitor VK-2019 in patients with advanced Epstein-Barr Virus-positive nasopharyngeal carcinoma, a rare type of head and neck cancer, and lymphoma.

Patients with melanoma who consumed a high-fiber diet may have a better response to immunotherapy, although the benefit was not as great if the fiber was obtained via probiotic supplements.